Table 2.
Echocardiographic results and follow up (*1 patient with an event 10 days after CV was excluded due to discontinuation of anticoagulation; abbreviations see text)
| Contrast-enhanced TEE | Control group | p value | |
|---|---|---|---|
| n |
90 |
90 |
|
|
thrombus detected (%) |
10 (11.1) |
10 (11.1) |
|
| LAA-flow (m/s) |
0.32 ±0.2 |
0.29 ±0.2 |
0.75 |
| LAA-flow ≤ 0.3m/s (%) |
7 (70) |
8 (80) |
0.606 |
| SEC (no/minor-moderate/ marked) |
2 / 6 / 2 |
0 / 4 / 6 |
0.111 |
| LA diameter (mm) |
47.6±7.2 |
50.1±6.1 |
0.429 |
|
thrombus excluded / unclear |
80 (88.9) |
80 (88.9) |
|
| LAA-flow (m/s) |
0.47 ±0.2 |
0.48 ±0.2 |
0.711 |
| SEC (no/minor-moderate/ marked) |
35 / 38 / 7 |
25 / 48 / 7 |
0.243 |
| LA diameter (mm) |
46.5±6.3 |
46.6±7.3 |
0.895 |
| CV performed (%) |
74 (82.2) |
76 (84.4) |
0.514 |
| CV related events (%) | 0 (0)* | 3 (3.9) | 0.084 |